Cargando…
Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
Autores principales: | Kar, Souvik, Perrelli, Andrea, Bali, Kiran Kumar, Mastrocola, Raffaella, Kar, Arpita, Khan, Bushra, Gand, Luis, Nayak, Arnab, Hartmann, Christian, Kunz, Wolfram S., Samii, Amir, Bertalanffy, Helmut, Retta, Saverio Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425784/ https://www.ncbi.nlm.nih.gov/pubmed/37588216 http://dx.doi.org/10.1016/j.gendis.2023.02.045 |
Ejemplares similares
-
Transcriptome-wide Profiling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures
por: Subhash, Santhilal, et al.
Publicado: (2019) -
Microsurgical management of midbrain cavernous malformations: does lesion depth influence the outcome?
por: Huang, Caiquan, et al.
Publicado: (2021) -
Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations
por: Antognelli, Cinzia, et al.
Publicado: (2020) -
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM)
por: Benedetti, Valerio, et al.
Publicado: (2022) -
Multifunctional Platinum@BSA–Rapamycin Nanocarriers
for the Combinatorial Therapy of Cerebral Cavernous Malformation
por: De Luca, Elisa, et al.
Publicado: (2018)